These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 11677365

  • 1. Angiotensin(1-7) potentiates bradykinin-induced vasodilatation in man.
    Ueda S, Masumori-Maemoto S, Wada A, Ishii M, Brosnihan KB, Umemura S.
    J Hypertens; 2001 Nov; 19(11):2001-9. PubMed ID: 11677365
    [Abstract] [Full Text] [Related]

  • 2. Angiotensin-(1-7) does not affect vasodilator or TPA responses to bradykinin in human forearm.
    Wilsdorf T, Gainer JV, Murphey LJ, Vaughan DE, Brown NJ.
    Hypertension; 2001 Apr; 37(4):1136-40. PubMed ID: 11304515
    [Abstract] [Full Text] [Related]

  • 3. Angiotensin-(1-7) augments bradykinin-induced vasodilation by competing with ACE and releasing nitric oxide.
    Li P, Chappell MC, Ferrario CM, Brosnihan KB.
    Hypertension; 1997 Jan; 29(1 Pt 2):394-400. PubMed ID: 9039133
    [Abstract] [Full Text] [Related]

  • 4. Angiotensin-(1-7) potentiates responses to bradykinin but does not change responses to angiotensin I.
    Greco AJ, Master RG, Fokin A, Baber SR, Kadowitz PJ.
    Can J Physiol Pharmacol; 2006 Nov; 84(11):1163-75. PubMed ID: 17218981
    [Abstract] [Full Text] [Related]

  • 5. Angiotensin-(1-7) potentiates the hypotensive effect of bradykinin in conscious rats.
    Paula RD, Lima CV, Khosla MC, Santos RA.
    Hypertension; 1995 Dec; 26(6 Pt 2):1154-9. PubMed ID: 7498987
    [Abstract] [Full Text] [Related]

  • 6. Angiotensin-(1-7) attenuates vasoconstriction evoked by angiotensin II but not by noradrenaline in man.
    Ueda S, Masumori-Maemoto S, Ashino K, Nagahara T, Gotoh E, Umemura S, Ishii M.
    Hypertension; 2000 Apr; 35(4):998-1001. PubMed ID: 10775575
    [Abstract] [Full Text] [Related]

  • 7. The angiotensin-converting enzyme gene polymorphism and responses to angiotensins and bradykinin in the human forearm.
    van Dijk MA, Kroon I, Kamper AM, Boomsma F, Danser AH, Chang PC.
    J Cardiovasc Pharmacol; 2000 Mar; 35(3):484-90. PubMed ID: 10710136
    [Abstract] [Full Text] [Related]

  • 8. Effect of NG-monomethyl-L-arginine on kinin-induced vasodilation in the human forearm.
    Cockcroft JR, Chowienczyk PJ, Brett SE, Ritter JM.
    Br J Clin Pharmacol; 1994 Oct; 38(4):307-10. PubMed ID: 7530473
    [Abstract] [Full Text] [Related]

  • 9. Comparison of angiotensin-converting enzyme inhibition with angiotensin II receptor antagonism in the human forearm.
    Cockcroft JR, Sciberras DG, Goldberg MR, Ritter JM.
    J Cardiovasc Pharmacol; 1993 Oct; 22(4):579-84. PubMed ID: 7505360
    [Abstract] [Full Text] [Related]

  • 10. Evidence for Mas-mediated bradykinin potentiation by the angiotensin-(1-7) nonpeptide mimic AVE 0991 in normotensive rats.
    Carvalho MB, Duarte FV, Faria-Silva R, Fauler B, da Mata Machado LT, de Paula RD, Campagnole-Santos MJ, Santos RA.
    Hypertension; 2007 Oct; 50(4):762-7. PubMed ID: 17664388
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Synergistic effect of angiotensin-(1-7) on bradykinin arteriolar dilation in vivo.
    Oliveira MA, Fortes ZB, Santos RA, Kosla MC, De Carvalho MH.
    Peptides; 1999 Oct; 20(10):1195-201. PubMed ID: 10573291
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.